BioSpace News Archive

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Virax Biolabs Group Limited, an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, announced that it has signed contracts to launch two new research and laboratory facilities in the United Kingdom.

July 18, 2023
·
6 min read
Drug Development

Grifols Completes Enrollment in Phase 3 Study of Long-term Albutein® (albumin-human injection) Therapy for Patients with Decompensated Cirrhosis

Grifols (MCE: GRF, MCE: GRF.P NASDAQ: GRFS) today announced it has completed enrollment in PRECIOSA (NCT03451292), its phase 3 clinical trial designed to determine the potential of long-term albumin treatment with Grifols Albutein® to increase survival time in patients with decompensated cirrhosis and ascites until a suitable transplant is available.

July 18, 2023
·
7 min read